Heart Rate
1
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
NovartisBASEL, Switzerland
1 program1
Phenylephrine HCLPhase 1/21 trial
Active Trials
NCT01026961Withdrawn0
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
NovartisPhenylephrine HCL
Heidelberg PharmaCool roof
Heidelberg PharmaCool roof
PfizerTreadmill testing
Clinical Trials (4)
Total enrollment: 1,036 patients across 4 trials
Safety of Phenylephrine Hydrochloride, Acetaminophen, Dimethindene Maleate Compared to Phenylephrine Hydrochloride Alone in Healthy Volunteers
Start: Sep 20100
Phase 1/2Withdrawn
Assessing the Effect of Cool Roofs on Health Using Smartwatches in Ouagadougou, Burkina Faso
Start: Mar 2025Est. completion: Mar 2026200 patients
N/ANot Yet Recruiting
Assessing the Effect of Cool Roofs on Health Using Smartwatches
Start: Sep 2024Est. completion: Sep 2027800 patients
N/AActive Not Recruiting
Heart Rate and Blood Pressure Response During Exercise and Sexual Activity in Normotensive and Hypertensive Volunteers
Start: May 2004Est. completion: Mar 200736 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space